Cardiac and Inflammatory Biomarker Differences in Adverse Cardiac Events after Chimeric Antigen Receptor T-Cell Therapy: An Exploratory Study

Researchers investigated the changes in cardiac and inflammatory biomarkers in CAR-T therapy to determine the role of pro-inflammatory cytokines.